Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published October 27, 1998 | Published
Journal Article Open

Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands

Abstract

Sequence-specific DNA-binding small molecules that can permeate human cells potentially could regulate transcription of specific genes. Multiple cellular DNA-binding transcription factors are required by HIV type 1 for RNA synthesis. Two pyrrole-imidazole polyamides were designed to bind DNA sequences immediately adjacent to binding sites for the transcription factors Ets-l, lymphoid-enhancer binding factor 1, and TATA-box binding protein. These synthetic ligands specifically inhibit DNA-binding of each transcription factor and HIV type 1 transcription in cell-free assays. When used in combination, the polyamides inhibit virus replication by >99% in isolated human peripheral blood lymphocytes, with no detectable cell toxicity, The ability of small molecules to target predetermined DNA sequences located within RNA polymerase II promoters suggests a general approach for regulation of gene expression, as well as a mechanism for the inhibition of viral replication.

Additional Information

© 1998 by the National Academy of Sciences. Contributed by Peter B. Dervan, August 20, 1998. We are grateful to the National Institutes of Health for grants to P.B.D, J.M.G., and D.E.M. for research support, the National Science Foundation and the Ralph M. Parsons Foundation for predoctoral fellowships to J.W.T., and the Howard Hughes Medical Institute for a predoctoral fellowship to E.E.B. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Attached Files

Published - DICpnas98.pdf

Files

DICpnas98.pdf
Files (304.2 kB)
Name Size Download all
md5:b226f63b844d7fe739e752ab8f9db322
304.2 kB Preview Download

Additional details

Created:
August 22, 2023
Modified:
October 23, 2023